<DOC>
	<DOCNO>NCT02149758</DOCNO>
	<brief_summary>The hypothesis Etoricoxib act adjuvant SRP alleviate periodontal inflammation : 1. improve clinical periodontal parameter , 2. improve salivary SOD level .</brief_summary>
	<brief_title>EFFECT OF SELECTIVE COX-2 INHIBITOR ( ETORICOXIB ) ALONG WITH SCALING AND ROOT PLANING ( SRP ) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND , PLACEBO-CONTROLLED , DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL ( RCT ) .</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Superoxide Dismutase</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<criteria>Forty patient chronic generalize periodontitis system illnesses , allergy , pregnancy , history drug intake periodontal treatment past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Cyclooxygenase two inhibitor</keyword>
	<keyword>Etoricoxib</keyword>
	<keyword>Periodontitis</keyword>
	<keyword>Superoxide dismutase</keyword>
	<keyword>Saliva</keyword>
</DOC>